Charles Wu has nearly 15 years of experience advising non-U.S. investors in a range of their investment activities in the United States, with a focus on Asian investors. He also acts for major U.S. and European private equity and buyout funds and multinationals on their investment and divestment activities in Greater China.
Charles acts for non-U.S. investors in private M&A, venture capital, foreign direct investment into the United States, spin-offs, public and private divestitures, and due diligence of U.S. companies and businesses. He has accumulated extensive experience in U.S. compliance matters related to cross-border transactions, including investment controls (particularly before the Committee on Foreign Investment in the United States [CFIUS], where he has secured approvals for both declarations and notice filings), export controls, sanctions, and related political developments.
Charles also acts for major U.S. and European private equity and buyout funds, sovereign wealth funds, and multinationals on their most consequential investment and divestment transactions in the Greater China market. He has significant practical knowledge of the People's Republic of China's (PRC) legal and business environment, which he integrates into the international documentation standards used by international investors.
Having been born in Beijing and raised in the United States (Mississippi and New Jersey), Charles leverages his diverse background in all his matters to earn trust and build bridges.
Experiencia
The following represents experience acquired prior to joining Jones Day.
Represented a leading global gaming development company based in Singapore in its acquisition of a gaming studio based in Oregon (U.S.), which included a successful CFIUS notice filing that resulted in a full, unconditional approval, and in its acquisition of a visual effects studio based in Los Angeles, California.
Represented a leading UK-based online payments company in the sale of its business to a leading Silicon Valley (U.S.) fintech company by way of a Delaware merger with a Bermuda parent.
Represented a Singapore-based private equity fund in its acquisition of all of the intellectual property assets of a pain therapy life sciences start-up based in California.
Represented a Singapore-based venture capital fund in its pre-IPO (initial public offering) investment in an AI (artificial intelligence) cancer diagnostics unicorn based in Maryland (U.S.).
Represented a Singapore-based venture capital fund in its co-investment in the Series B financing of a leading robotics software unicorn based in Pittsburgh, Pennsylvania.
Represented the sovereign wealth fund of a Middle Eastern Gulf state in its participation as a cornerstone investor in the Hong Kong IPO of CATL.
Represented the sovereign wealth fund of a Western European country in the extension and restructuring of two joint venture investment funds entered into with national agencies of the Chinese government and a leading French investment bank.
Represented a leading U.S. private equity buyout fund in its due diligence and acquisition of a portfolio of music assets in the PRC and Taiwan and its subsequent divestment.
Represented a leading UK private equity buyout fund in its PRC due diligence regarding the acquisition of a majority stake in an education business.
Represented a leading U.S. hospitality multinational in its formation of a travel joint venture with a BATJ (Baidu, Alibaba, Tencent, JD.com) targeting PRC consumers and its subsequent establishment and operations.
- Rutgers University (J.D. 2010); University of Michigan (B.A. 2007)
- New York (USA), New Jersey (USA), and Hong Kong
- English and Mandarin